The Russian laboratory has provided scientific studies and affirms that the vaccine is safe

On December 24, the South American nation received the first 300,000 doses out of a total order of over 10 million doses of the Russian Sputnik V vaccine. In the first round it has prioritized the health workers for the administration of the vaccine.

India’s mass vaccination plans may fail if it does not hold open discussions on its plans with health professionals and the people

As trials for vaccine candidates continue, the question of which countries will gain access to it has become pressing. Low-income countries are likely to suffer in this regard

The new vaccine candidate by Moderna Inc, called mRNA-1273, has reportedly shown 94.5% efficacy against the SARS-CoV-2 in the phase III clinical trials

Newsclick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss the challenges of taking a vaccine to the people in countries like India. They also look at the various vaccine candidates in contention

According to a recent study by Oxfam International, wealthy nations, which account for nearly 13% of the global population, have cornered a lion’s share of supply deals for vaccine candidates in phase-3 of the clinical trials